Ernexa Therapeutics appoints Robert J. Spiegel to board
Ernexa Therapeutics appointed biopharmaceutical executive Robert J. Spiegel, M.D., FACP, to its Board of Directors. The company said the appointment strengthens the board as it advances ERNA-101 toward clinical development.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.